marijuana stocks news

Form 8-K/A for SURNA INC.


3-Mar-2015

Change in Directors or Principal Officers, Financial Statements and Exhibits

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On February 24, 2015, Tom Bollich submitted his resignation as President, Chief Executive Officer, Chairman of the Board and a member of the Board of Directors of Surna Inc. (“Surna” or the “Company”), effective April 15, 2015. Mr. Bollich did not resign because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Bryon Jorgenson will succeed Mr. Bollich as Chief Executive Officer of Surna. Mr. Jorgenson, age 52, joined the Company in January 2015 as Chief Operating Officer. He has more than 25 years of experience at the executive-level and engineer in industrial electronics, life sciences and industrial automation systems sectors. His career has focused on business development functions including product commercialization, pre-acquisition due diligence, business integration, management team transition, and operations performance improvement. From 2012 until January 2015, Mr. Jorgenson was the Chief Operations Officer and founder of MIROPEX, LLC, a management consulting organization serving technology-based companies. In that capacity, he was focused on business development functions including product commercialization, pre-acquisition due diligence, business integration, management team transition, and operations performance improvement. Prior to forming MIROPEX, LLC, Mr. Jorgenson was Senior Director of Operations and Engineering at St. Jude Medical’s Cardiovascular Division from 2009 to 2012. In this role, he led several engineering functions comprising over 180 staff members, supported multiple mergers and acquisitions transactions, and established project management office systems and training for SJM-Cardiology Division’s global operations organization. There will be no changes to Mr. Jorgenson’s compensation as a result of his appointment as Chief Executive Officer. For additional information regarding Mr. Jorgenson’s background and compensation, see the Company’s current report on Form 8-K filed with the Securities and Exchange Commission on January 8, 2015.

 

Item 9.01. Financial Statements and Exhibits.(d) Exhibits.

Exhibit No.   Description of Exhibit

   99.1       Press release of the Company dated February 26, 2015 (incorporated
              by reference to Exhibit 99.1 to the Company's current report on Form
              8-K filed on February 26, 2015).

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) Reports First Quarter 2022 Financial Results

Cara Therapeutics Reports First Quarter 2022 Financial Results Cara Therapeutics, Inc. (Nasdaq:…

TILT Holdings Inc. (TLLTF) Commonwealth Alternative Care (CAC) Dispensary Celebrates in Taunton This Weekend

TILT Holdings’ Commonwealth Alternative Care (CAC) Dispensary Celebrates in Taunton This Weekend…

$AFI Signed LOI With North Country Natural Solutions LLC in NY State

Affinor Growers Signs LOI With North Country Natural Solutions LLC in New…

AbbVie (ABBV) to Host Third-Quarter 2023 Earnings Conference Call

AbbVie to Host Third-Quarter 2023 Earnings Conference Call AbbVie (NYSE: ABBV) will…